Notice of Special Interest: Administrative Supplements to Support Emerging Physician-Scientists to Develop Research Expertise in Diabetes, Endocrinology and Metabolic Diseases (NOT-DK-23-021)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

The purpose of the NIDDK’s Division of Diabetes, Endocrinology and Metabolic Diseases (DDEMD) Administrative Supplement Program is to enable additional clinical perspectives to be brought to on-going research projects within the Division’s mission and to enhance the research expertise of selected physicians. The program will provide supplementary funds to support advanced research opportunities for exceptional emerging physician-scientists (hereafter, “candidates”) holding the MD or equivalent or MD/PhD degrees, and who are early in their research careers.

The supplement is intended to allow candidates to expand their research experience to help them transition beyond their clinical training to the next stage of their research careers as physician-scientists.

Administrative supplements must support work within the scope of a currently funded basic, behavioral, and/or clinical DDEMD research project. PIs of projects focused on type 1 diabetes are highly encouraged to apply given the limited numbers of new MD researchers entering this area. All applicants are strongly encouraged to discuss potential requests with the NIDDK DDEMD program director of the award for which they wish to submit a supplement application. See https://www.niddk.nih.gov/about-niddk/staff-directory/by-office/division-diabetes-endocrinology-metabolic-diseases for DDEMD program director contact information.

Application due date: February 6, 2025
Expiration date: February 7, 2025

National NIH K12 DiabDocs Program (DiabDocs Program)

The DiabDocs program is now soliciting a fourth cycle of letters of intent for applications for our mentored career development program from early career physician scientists engaged in research relevant to diabetes and within the scope of NIDDK including basic, translational, clinical, epidemiology/biostatistical, informatics, health services or health policy projects. Most funded scholars will focus on type 1 diabetes (T1D) research, and limited slots are available for persons working in type 2 diabetes (T2D).

Letter of Intent Due Date: November 12, 2024
Application Due Date: January 13, 2025

Notice of NIDDK’s Participation in PAR-23-237 -Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed) (PAR-23-237)

The purpose of this notice is to inform potential applicants that the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) will participate, effective immediately in PAR-23-237, Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed).

Application due date: January 26, 2025 

Follow
×

Follow

us on our social networks.